CIK 0001087294 · Non-accelerated filer<br>Smaller reporting company
CUMBERLAND PHARMACEUTICALS INC
Sign in to watch- Ticker
- CPIX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- TN
- Entity type
- operating
- EIN
- 621765329
- Phone
- 615-255-0068
- Business address
- 1600 WEST END AVENUE, SUITE 1300, NASHVILLE,, TN, 37203
- 4 Open-market buy Chairman and CEO bought 186 shares at an average $4.48 ($833)
- 4 Open-market buy Director bought 1,035 shares at an average $4.48 ($4,635)
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- 8-K Event Shareholder vote results
- SCHEDULE 13G/A Stake Statement of Beneficial Ownership
- 4 Open-market buy Director bought 74 shares at an average $5.18 ($384)
- 4 Open-market buy Director bought 168 shares at an average $5.24 ($881)
- 4 Open-market buy Chairman and CEO bought 168 shares at an average $5.24 ($881)
- 4 Open-market buy Director bought 875 shares at an average $5.20 ($4,548)
- 8-K Event Other events
- ARS Other Annual Report to Security Holders
- 4 Grant or award Director acquired 1,000 shares (grant or award)
- 4 Grant or award Director acquired 5,000 shares (grant or award)
- 4 Grant or award Director acquired 1,000 shares (grant or award)
- 4 Grant or award Director acquired 1,000 shares (grant or award)
- 4 Grant or award Director acquired 1,000 shares (grant or award)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
Page 5 of 52 · 1,039 filings